3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Condylomata Acuminata
3
Warts
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Tobacco Use Cessation Devices
2
Surveys and Questionnaires
2
Nivolumab
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Electrocoagulation
2
Biopsy
2
fludarabine phosphate
1
fludarabine
1
Watchful Waiting
1
Trichloroacetic Acid
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Tacrolimus
1
Self Care
1
Ritonavir
1
Registries
1
Rapid Diagnostic Tests
1
Proctoscopy
1
Papillomavirus Vaccines
1
Occult Blood
1
Observation
1
Nevirapine
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Melphalan
1
Mass Screening
1
Mammography
1
Lopinavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Acquired Immunodeficiency Syndrome
×
Trichloroacetic Acid
×
Clear all
NCT02615860
2022-11-08
TECAIN
University Hospital, Essen
Phase NA
Completed
560 enrolled